CN106008564B - 笼状2‑(2‑吡啶基)苯并咪唑锌配合物及其制备方法和应用 - Google Patents
笼状2‑(2‑吡啶基)苯并咪唑锌配合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN106008564B CN106008564B CN201610380662.5A CN201610380662A CN106008564B CN 106008564 B CN106008564 B CN 106008564B CN 201610380662 A CN201610380662 A CN 201610380662A CN 106008564 B CN106008564 B CN 106008564B
- Authority
- CN
- China
- Prior art keywords
- pyridine radicals
- benzimidazole
- complex
- caged
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 2 pyridine radicals Chemical class 0.000 title claims abstract description 23
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000011701 zinc Substances 0.000 claims abstract description 20
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004626 polylactic acid Substances 0.000 claims abstract description 11
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims abstract description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 5
- HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 14
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 5
- 239000013078 crystal Substances 0.000 claims description 5
- 235000019441 ethanol Nutrition 0.000 claims description 5
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- 150000002460 imidazoles Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 18
- 239000003054 catalyst Substances 0.000 abstract description 11
- 238000006555 catalytic reaction Methods 0.000 abstract description 4
- 230000035484 reaction time Effects 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 150000001556 benzimidazoles Chemical class 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000003197 catalytic effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 9
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 229960004217 benzyl alcohol Drugs 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 230000005311 nuclear magnetism Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- ORQUWXSKWZRTGJ-UHFFFAOYSA-N 1H-benzimidazole hexane Chemical compound N1=CNC2=C1C=CC=C2.CCCCCC ORQUWXSKWZRTGJ-UHFFFAOYSA-N 0.000 description 1
- IPLQBXKYVKVYHY-UHFFFAOYSA-N 1h-benzimidazole;zinc Chemical compound [Zn].C1=CC=C2NC=NC2=C1 IPLQBXKYVKVYHY-UHFFFAOYSA-N 0.000 description 1
- WMHGLLZEVOPGQD-UHFFFAOYSA-N 2h-pyridine-1-carbaldehyde Chemical compound O=CN1CC=CC=C1 WMHGLLZEVOPGQD-UHFFFAOYSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/06—Zinc compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
- C08G63/82—Preparation processes characterised by the catalyst used
- C08G63/83—Alkali metals, alkaline earth metals, beryllium, magnesium, copper, silver, gold, zinc, cadmium, mercury, manganese, or compounds thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Polyesters Or Polycarbonates (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
本发明提供了一种笼状2‑(2‑吡啶基)苯并咪唑锌配合物及其制备方法和应用。该方法是以2‑(2‑吡啶基)苯并咪唑为配体,并以此配体为转移试剂,与二乙基锌试剂作用合成一种笼状的2‑(2‑吡啶基)苯并咪唑锌配合物,这种笼状的金属锌配合物可用于催化丙交酯的开环聚合。本发明配合物的制备方法简便,原料易得,反应条件温和,产率高;对丙交酯开环聚合反应合成生物可降解的聚乳酸材料具有较高催化活性,并由于这类催化剂的生物相容性好、毒性小,对环境污染小,催化反应时间短,产率高,有很好的工业应用前景。
Description
技术领域
本发明涉及催化剂制备技术领域,具体涉及一种笼状2-(2-吡啶基)苯并咪唑锌配合物及其制备方法和应用。
背景技术
基于α-羟基酸(乙二醇,乳酸)的聚酯有可降解性,同时其水解后的产物有生物相容性。其中聚乳酸(PLA)作为一种新型友好的热塑性塑料有着广泛的用途:纤维,涂料,薄膜等。乳酸合成来源是玉米、甜菜、或者其他可再生的资源,可作为一种石油衍生聚合物的替代品,进而缓解人类资源危机染。PLA不但具有一般高分子材料所具有的基本特性,而且极易改性以满足各种需要;其已在医疗、工业、农业等领域得到广泛应用,并且除具有高分子的特点外,还有良好的生物相容性且无毒性的优点,因而被认为是21世纪最有前途的可生物降解的功能材料。目前,丙交酯的开环聚合反应相对于缩聚反应有更多优点,如条件温和,单体转化率高,易得高分子量且分子量窄的聚乳酸等,而成为现今研究最深入的方法。所用催化剂主要有铝系、锌系、镁系、钙系及锡系等。锌配合物催化剂因其毒性小与可控的聚合物分子量等特点被广泛研究。但是大部分锌配合物催化剂存在常温下反应时间较长、催化产率低、聚合物分子量分布不均匀的问题。
发明内容
本发明的目的是提供一种笼状2-(2-吡啶基)苯并咪唑锌配合物及其制备方法,配合物合成简便,反应条件温和,产率高;配合物对丙交酯开环聚合反应合成生物可降解的聚乳酸材料具有在常温下反应时间短、催化产率高、聚合物分子量分布均匀的特点。
本发明提供的一种笼状2-(2-吡啶基)苯并咪唑锌配合物,其结构式为:
式中:该配合物呈现笼状构型,由四个(2-(2-吡啶基)苯并咪唑)乙基锌分子通过四个N-Zn配位键构成;其中锌原子与乙基碳原子、配体上两个氮原子及另一配体的氮原子形成四配位模式,并且每个锌原子均连接向外伸展的乙基。
本发明提供的一种笼状2-(2-吡啶基)苯并咪唑锌配合物的制备方法,包括如下步骤:
(1)将吡啶甲醛在0℃缓慢滴入到邻苯二胺的乙醇溶液中,室温反应4小时,抽干溶剂后得大量淡黄色固体,用正己烷洗涤两次,然后用无水乙醇重结晶得2-(2-吡啶基)苯并咪唑配体;反应式:
(2)在惰性气体保护下,将等当量的二乙基锌试剂在-78℃逐滴滴加到2-(2-吡啶基)苯并咪唑的正己烷溶液中,恢复室温后继续搅拌2小时,反应完毕后过滤重结晶,室温析出无色透明晶体,即为笼状2-(2-吡啶基)苯并咪唑锌配合物,产率91-94%。反应式:
步骤1)中吡啶甲醛与邻苯二胺的摩尔比为2∶1。
该催化剂可在催化丙交酯开环聚合反应中应用。
与现有技术相比本发明的优点和效果:本发明配合物的制备方法简便,原料易得,反应条件温和,产率较高;在其笼状结构上存在四个向外伸展的乙基活性基团,更有利于丙交酯开环聚合反应的进行,因此具有较高催化活性且所生成的聚乳酸分子量分布均匀,由于这类催化剂的生物相容性好、毒性小,对环境污染小,催化反应时间短,产率高,有很好的工业应用前景。
附图说明
图1本发明一种笼状2-(2-吡啶基)苯并咪唑锌配合物的单晶X射线结构图
具体实施方式:
以下仅仅为详细说明本发明而给出的具体实施例,这些实施例并非用于限制本发明的保护范围。
实施例1笼状2-(2-吡啶基)苯并咪唑锌配合物的制备
将吡啶甲醛(2.14g,20mmol)在0℃缓慢滴入到邻苯二胺(1.08g,10mmol)的乙醇溶液中,室温反应4小时,抽干溶剂后得大量淡黄色固体,分别用5mL正己烷洗涤两次,然后用无水乙醇重结晶得2-(2-吡啶基)苯并咪唑配体,产率94%;
在惰性气体保护下,将二乙基锌试剂(2.0mL,1.0M,正己烷溶液)在-78℃逐滴滴加到2-(2-吡啶基)苯并咪唑(2.31g,2mmol)的正己烷溶液中,恢复室温后继续搅拌2小时,反应完毕后过滤重结晶,室温析出无色透明晶体,即为笼状2-(2-吡啶基)苯并咪唑锌配合物,产率97%。
晶体参数:化学式:C56H52N12Zn4,三斜晶系(triclinic),空间群P1,晶胞参数 α=97.551(3)°,β=107.060(3)°,γ=105.469(3)°,V=2920.5(5),Z=1。单晶结构图见图1。
部分键长:Zn1-C13 1.964(15),Zn1-N1 2.164(16),Zn1-N3 2.023(19),Zn1-N5 2.105(18),Zn2-C27 1.90(3),Zn2-N4 2.18(2),Zn2-N6 2.071(18),Zn2-N8 2.023(18),Zn3-C41 1.88(3),Zn3-N7 2.20(2),Zn3-N9 2.058(17),Zn3-N11 2.133(17),Zn4-C55 2.02(2),Zn4-N10 2.16(2),Zn4-N12 2.06(2),Zn4-N2 2.083(17);键角(°):C13-Zn1-N3 113.6(7),C13-Zn1-N5 118.9(6),N3-Zn1-N1 79.7(6),N5-Zn1-N1 95.7(6),N3-Zn1-N5116.6(7),C13-Zn1-N1 125.9(7),C27-Zn2-N8 132.3(11),C27-Zn2-N4 118.4(11),C27-Zn2-N6 114.6(11),N8-Zn2-N6 107.8(8),N8-Zn2-N4 90.9(8),N6-Zn2-N4 77.2(8),C41-Zn3-N9 119.9(11),C41-Zn3-N11 116.1(10),C41-Zn3-N7 125.1(11),N9-Zn3-N11 117.1(7),N9-Zn3-N7 78.8(7),N11-Zn3-N7 91.4(7),C55-Zn4-N12 128.5(8),C55-Zn4-N2116.4(9),C55-Zn4-N10 122.5(8),N12-Zn4-N2 106.6(7),N12-Zn4-N10 76.9(7),N2-Zn4-N10 96.2(7)。
实施例2
(1)催化剂的制备同实施例1
(2)丙交酯开环聚合:将丙交酯(1.44g,10mmol)和催化剂(0.1mmol)溶入20mL四氢呋喃溶剂中,待溶液澄清后,加入苄醇(0.4mmol)进行引发,25℃反应1小时后取少量反应混合液用于核磁1H NMR检测转化产率,然后加入0.5mL HCl(1.0M)的乙醇溶液对反应进行终止,再缓慢加入无水乙醇沉淀聚乳酸,静置后过滤,真空干燥得白色聚乳酸固体产品。转化率99%,PDI=1.16。
实施例3
(1)催化剂的制备同实施例1
(2)丙交酯开环聚合:将丙交酯(7.20g,50mmol)和催化剂(0.1mmol)溶入30mL四氢呋喃溶剂中,待溶液澄清后,加入苄醇(0.4mmol)进行引发,25℃反应1小时后取少量反应混合液用于核磁1H NMR检测转化产率,然后加入0.5mL HCl(1.0M)的乙醇溶液对反应进行终止,再缓慢加入无水乙醇沉淀聚乳酸,静置后过滤,真空干燥得白色聚乳酸固体产品。转化率98%,PDI=1.11。
Claims (4)
1.一种笼状2-(2-吡啶基)苯并咪唑锌配合物,其特征在于,结构式为:
2.如权利要求1所述的一种笼状2-(2-吡啶基)苯并咪唑锌配合物的制备方法,其特征在于,包括如下步骤:
1)将吡啶甲醛在0℃缓慢滴入邻苯二胺的乙醇溶液中,室温反应4小时,抽干溶剂后得大量淡黄色固体,用正己烷洗涤两次,然后用无水乙醇重结晶得2-(2-吡啶基)苯并咪唑配体;
2)在惰性气体保护下,将等当量的二乙基锌试剂在-78℃逐滴滴加到2-(2-吡啶基)苯并咪唑的正己烷溶液中,恢复室温后继续搅拌2小时,过滤重结晶,室温析出无色透明晶体即可。
3.如权利要求2所述的一种笼状2-(2-吡啶基)苯并咪唑锌配合物的制备方法,其特征在于,所述步骤1)中吡啶甲醛与邻苯二胺的摩尔比为2∶1。
4.如权利要求1所述的笼状2-(2-吡啶基)苯并咪唑锌配合物在催化丙交酯开环聚合反应制备聚乳酸材料中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610380662.5A CN106008564B (zh) | 2016-06-01 | 2016-06-01 | 笼状2‑(2‑吡啶基)苯并咪唑锌配合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610380662.5A CN106008564B (zh) | 2016-06-01 | 2016-06-01 | 笼状2‑(2‑吡啶基)苯并咪唑锌配合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106008564A CN106008564A (zh) | 2016-10-12 |
CN106008564B true CN106008564B (zh) | 2017-10-17 |
Family
ID=57092857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610380662.5A Expired - Fee Related CN106008564B (zh) | 2016-06-01 | 2016-06-01 | 笼状2‑(2‑吡啶基)苯并咪唑锌配合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106008564B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107501535B (zh) * | 2017-08-14 | 2019-11-12 | 常州大学 | 用于开环聚合制备聚乳酸的锌配合物催化剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102311539A (zh) * | 2011-07-09 | 2012-01-11 | 山西大学 | 三核有机锌催化剂及其制备方法和应用 |
CN103923110A (zh) * | 2014-04-03 | 2014-07-16 | 哈尔滨工业大学 | 具有抗菌活性的苯并咪唑衍生物金属配合物及其制备方法 |
-
2016
- 2016-06-01 CN CN201610380662.5A patent/CN106008564B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102311539A (zh) * | 2011-07-09 | 2012-01-11 | 山西大学 | 三核有机锌催化剂及其制备方法和应用 |
CN103923110A (zh) * | 2014-04-03 | 2014-07-16 | 哈尔滨工业大学 | 具有抗菌活性的苯并咪唑衍生物金属配合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
6-苯并咪唑基-2-芳亚胺乙基吡啶锌配合物的合成及其对苯乙烯聚合的催化性能;肖立伟 等;《Chin. J. Org. Chem.》;20130407;第33卷;第1828-1833页 * |
Magnesium and Zinc Complexes Supported byN,O-Bidentate Pyridyl Functionalized Alkoxy Ligands: Synthesis and Immortal ROP of ε-CL and L-LA;Yang Wang et al.;《Organometallics》;20120329;第31卷;第4182-4190页 * |
Synthesis, crystal structure and luminescent properties of transition metals complexes based on imidazole derivatives;Shumei Yue et al.;《Synthetic Metals》;20120109;第162卷;第247-256页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106008564A (zh) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Milione et al. | Neutral and cationic heteroscorpionate aluminum complexes: Synthesis, structure, and ring-opening polymerization of ε-caprolactone | |
Sánchez-Barba et al. | Well-defined alkyl heteroscorpionate magnesium complexes as excellent initiators for the ROP of cyclic esters | |
Moore et al. | Synthesis and characterization of water-soluble silver and palladium imidazol-2-ylidene complexes with noncoordinating anionic substituents | |
Ireland et al. | Cationic organomagnesium complexes as highly active initiators for the ring-opening polymerization of ε-caprolactone | |
Sentman et al. | Silver (I)− Carbene Complexes/Ionic Liquids: Novel N-Heterocyclic Carbene Delivery Agents for Organocatalytic Transformations | |
Pinaud et al. | Poly (N-heterocyclic-carbene) s and their CO2 adducts as recyclable polymer-supported organocatalysts for benzoin condensation and transesterification reactions | |
Lamberti et al. | Phenoxy-thioether aluminum complexes as ε-caprolactone and lactide polymerization catalysts | |
Wheaton et al. | Activated zinc complexes supported by a neutral, phosphinimine-containing ligand: Synthesis and efficacy for the polymerization of lactide | |
Bakewell et al. | 8-Quinolinolato gallium complexes: iso-selective initiators for rac-lactide polymerization | |
Wang et al. | Bridged bis (amidinate) ytterbium alkoxide and phenoxide: syntheses, structures, and their high activity for controlled polymerization of L-lactide and ε-caprolactone | |
Sharma et al. | Bis (1, 3-di-tert-butylimidazolin-2-iminato) titanium complexes as effective catalysts for the monodisperse polymerization of propylene | |
Castro-Osma et al. | Catalytic behaviour in the ring-opening polymerisation of organoaluminiums supported by bulky heteroscorpionate ligands | |
Otero et al. | Scandium and Yttrium Complexes Supported by NNCp Heteroscorpionate Ligands: Synthesis, Structure, and Polymerization of ϵ-Caprolactone | |
Davidson et al. | Synthesis and X-ray structures of new titanium (IV) aryloxides and their exploitation for the ring opening polymerization of ε-caprolactone | |
Arndt et al. | Synthesis and reactions of tungsten alkylidene complexes that contain the 2, 6-dichlorophenylimido ligand | |
Guo et al. | Highly linear polyethylenes achieved using thermo-stable and efficient cobalt precatalysts bearing carbocyclic-fused NNN-pincer ligand | |
Kim et al. | Removable water-soluble olefin metathesis catalyst via host–guest interaction | |
Hao et al. | Aluminum complexes containing the c–o–al–o–c framework as efficient initiators for ring-opening polymerization of ε-caprolactone | |
WO2018140987A1 (en) | Titanium-organic framework material | |
Wallenhorst et al. | Bis (iminoethyl) pyridine systems with a pendant alkenyl group. Part A: cobalt and iron complexes and their catalytic behavior | |
CN106008564B (zh) | 笼状2‑(2‑吡啶基)苯并咪唑锌配合物及其制备方法和应用 | |
Guo et al. | 2-Aminopyrrolyl dilithium compounds: Synthesis, structural diversity, and catalytic activity for amidation of aldehydes with amines | |
Garcés et al. | Organo-aluminum and zinc acetamidinates: Preparation, coordination ability, and ring-opening polymerization processes of cyclic esters | |
Jia et al. | Syntheses, reactions, and ethylene polymerization of titanium complexes with [N, O, S] ligands | |
Wang et al. | Lithium, Magnesium, and Zinc Iminophosphorano (8-quinolyl) methanide Complexes: Syntheses, Characterization, and Activity in ε-Caprolactone Polymerization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171017 Termination date: 20200601 |
|
CF01 | Termination of patent right due to non-payment of annual fee |